Obsidian Financial Communications Inc.
Friday, May 18, 2012
Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting
http://ow.ly/1jRjxM
Newer Post
Older Post
Home